Download Free Sample Report

The global Poliomyelitis Vaccines market was valued at US$ 730.3 million in 2022 and is projected to reach US$ 850.6 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.
This report aims to provide a comprehensive presentation of the global market for Poliomyelitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomyelitis Vaccines. This report contains market size and forecasts of Poliomyelitis Vaccines in global, including the following market information:

• Global Poliomyelitis Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Poliomyelitis Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
• Global top five Poliomyelitis Vaccines companies in 2022 (%)

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 99% market shares.
We surveyed the Poliomyelitis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poliomyelitis Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliomyelitis Vaccines Market Segment Percentages, by Type, 2022 (%)

• IPV
• OPV

Global Poliomyelitis Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliomyelitis Vaccines Market Segment Percentages, by Application, 2022 (%)

• Research & Academic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Global Poliomyelitis Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliomyelitis Vaccines Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poliomyelitis Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Poliomyelitis Vaccines revenues share in global market, 2022 (%)
Key companies Poliomyelitis Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Poliomyelitis Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• GSK
• Bibcol
• Serum Institute
• Tiantan Biological
• IMBCA
• Panacea Biotec Ltd
• Bio-Med
• Halfkin Bio-Pharmaceuticals

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Poliomyelitis Vaccines, market overview.
• Chapter 2: Global Poliomyelitis Vaccines market size in revenue and volume.
• Chapter 3: Detailed analysis of Poliomyelitis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Poliomyelitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Poliomyelitis Vaccines capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.